DEXCOM INC Quarterly Depreciation in USD for Q4 2017

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Dexcom Inc annual/quarterly Depreciation history and growth rate for Q4 2017.
  • Dexcom Inc Depreciation for the quarter ending December 31, 2017 was $16.1M.
  • Dexcom Inc annual Depreciation for 2023 was $147M, a 2.29% increase from 2022.
  • Dexcom Inc annual Depreciation for 2022 was $144M, a 49.6% increase from 2021.
  • Dexcom Inc annual Depreciation for 2021 was $96.3M, a 50.5% increase from 2020.
Depreciation, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2017 $16.1M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.